MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Stryker Biotech to pay $1.35 million to settle Bay State beef

Stryker Biotech to pay $1.35 million to settle Bay State beef

By

SYK logo

It took less than 24 hours for Stryker Corp. (NYSE:SYK) to settle a lawsuit filed against its Bay State-based biotech division by Mass. attorney general Martha Coakley for $1.35 million.

Coakley sued Hopkinton, Mass.-based Stryker Biotech yesterday, accusing the firm of illegally promoting the combined use of a pair of its bone growth products and of falsifying Institutional Review Board documents. A settlement, announced this morning, will see Stryker pay $325,000 in civil penalties, $875,000 into an anti-false marketing and consumer protection fund and $150,000 in legal and investigative costs. In a statement emailed late in the day Aug. 27, Stryker said the settlement “does not include any admission of liability.”

The lawsuit accused the company of "subverting clinical and medical review procedures designed to protect patient safety" in falsifying the IRB documents, promoting the use of products in applications not approved by the Food & Drug Administration and "failing to disclose information to Massachusetts physicians and medical professionals about restrictions imposed on the use of its products," according to the complaint.

The case involves separate bone-healing products, each granted a narrow, provisional “humanitarian device exemption” by the FDA. Stryker and four former executives are also fighting a federal beef for allegedly promoting the combination of its OP-1 Implant, OP-1 Putty and the bone void filler Calstrux.

Former Stryker Biotech president Mark Philip and sales managers David Ard, Jeff Whitaker and William Heppner, were indicted by a grand jury on charges of wire fraud and conspiracy. Stryker and Philip were also charged with making false statements to the FDA. Heppner was the company’s national sales director; Ard and Whitaker were regional managers for the western and central territories, respectively.

The federal indictment charges that Stryker and Philip lied to the FDA about the number of patients treated each year with OP-1 Putty. According to a regulatory filing, "certain former Stryker Biotech employees have pled guilty to charges in connection with this matter." If Stryker is found guilty, it could be excluded from "participating in federal and state health care programs, which could have a material effect on Stryker Biotech’s business," according to the filing.

Calls and emails to Stryker seeking comment were not immediately returned.

In case you missed it

RSS From Medical Design & Outsourcing

  • DTW Podcast: Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?
    In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith+Nephew. We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team… […]
  • Mahr adds sales, quality managers
    Mahr (Providence, R.I.) announced today that Josh Howlett has joined the company as Northeast regional sales manager, and Celina Ortiz has been appointed manager of quality assurance. Howlett has held sales management positions at Zeiss Industrial Metrology and HGH Infrared Systems, and most recently served as regional sales manager for Koma Precision. He studied Business… […]
  • Advamed: Diagnostic COVID-19 tests shipments hit 200M
    Total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million, according to AdvaMed’s COVID-19 diagnostic supply registry. A breakdown of the data shows that diagnostics companies are shipping, on average, more than 1.4 million molecular tests each day. “For the past few months, our diagnostics companies have made it clear they’ll do whatever… […]
  • FundamentalVR expands into ophthalmology
    FundamentalVR today announced it is expanding its surgical specialty capabilities to include ophthalmology. The Boston-based company said it will use its HapticVRTM technology architecture, designed to mimic the physical cues of surgical actions, medical tools, and tissue variations, to create data-driven medical educational simulations for ophthalmology as well as orthopedic device and pharmaceutical brands. Fundamental… […]
  • Enhancing the Reliability of Pregnancy Tests with High-Performing Wicks
    By Natalie Schlage, Strategic Marketing Manager – Diagnostics, Porex When it comes to life-changing tests, the accuracy of the results is non-negotiable. Every year millions of women rely on home pregnancy tests to deliver potentially life altering news. In fact, according to Statistica, 8.8 million women in the United States used a home pregnancy test… […]
  • Bruker launches next-gen Fourier 80 benchtop spectrometer
    Bruker this week announced it launched its next-generation Fourier 80 benchtop spectrometer system. Fourier 80 is an 80 MHz Fourier Transform Nuclear Magnetic Resonance benchtop spectrometer that is equipped for gradient spectroscopy. It is designed for organic or medicinal chemistry analysis, NMR teaching, synthesis verification or routine analysis in a chemistry lab. The Fourier 80… […]
  • Minnetronix lands NIH grant to study spinal fluid treatment tech
    Minnetronix Medical today announced that it has been awarded a National Institutes of Health (NIH) grant for continued study of its proprietary Neurapheresis cerebrospinal fluid treatment platform. Akin to hemodialysis, the Neurapheresis platform is designed to rapidly remove blood cells and their cytotoxic byproducts that are released into cerebrospinal fluid following an aneurysmal subarachnoid hemorrhage.… […]
  • How SpaceX is helping Medtronic prepare for the next pandemic wave
    As COVID-19 cases erupted around the globe earlier this year, Medtronic (NYSE:MDT) faced unprecedented demand for its ventilators. At first, Medtronic engineer Matt Phillips wasn’t sure how the company was going to supply enough ventilators to meet the surging global need. Then Elon Musk called with a proposal. Space Exploration Corporation (SpaceX), Elon Musk’s California-based company… […]
  • Could hydrogels and magnetic fields grow new cartilage?
    Researchers at the University of Pennsylvania are touting a new way to potentially rebuild complex body tissues to fix common injuries like cartilage degeneration. Following the publication of research in Advanced Materials, those involved are suggesting that the rebuilding process for these body tissues could be done by using a magnetic field and hydrogels, according to… […]
  • U of M researchers receive $6.6M to develop neuromod device for mental health
    Researchers at the University of Minnesota were last month awarded a $6.6 million grant to develop a device for treating mental health disorders. The National Institute of Mental Health provided the grant award in support of the development of a new medical device for treating those disorders by using brain rhythms, something that hasn’t been… […]
  • Stryker launches ‘smart’ hospital bed
    Stryker today announced the global launch of the industry’s first and only completely wireless hospital bed, ProCuity. ProCuity was designed to help reduce in-hospital patient falls at all acuity levels, improve nurse workflow and safety, and help lower hospital costs, according to Kalamazoo, Mich.-based Stryker. It is the only bed on the market today that… […]

Leave a Reply